Austar Lifesciences saw huge demand that put its initial public offering in Hong Kong about 1,250 times oversubscribed, prompting the company to increase the number of allotted shares to float.
via South China Morning Post - Business feed http://ift.tt/1x7MgmD
Labels: Business, China, Hong Kong